ITI Pharma and Healthcare Fund Regular - Growth
Mutual Fund Details – Invest Smart, Grow Wealth
Discover a variety of mutual funds tailored to your goals, from equity and debt to hybrid options. Track performance, compare funds, and get expert insights to make informed investment decisions. Grow your wealth with Motilal Oswal’s trusted mutual fund solutions.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return -2.93% at 16 Feb 2026 03:53 PM
Fund Details
NAV 15.0528
Sub-Type Sectoral-Pharma
Rating 1
Min. SIP Amount ₹500.0
Fund Age(Year) 4.27
Fund Size(in Crores) 210.45
Fund Performance
1 Month -2.97%
3 Month -7.24%
6 Month -8.53%
1 Year -2.93%
3 Year 18.23%
5 Year 0.0%
Know This Fund
As on 16 Feb 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (98.24%) Market Cap Small Cap 27.26 Large Cap 34.13 Mid Cap 36.85 Top Sectors Healthcare 93.39 Chemicals 2.54 Insurance 1.41 Capital Goods 0.9 Top Holding Astrazeneca Pharma India 0.76 Standard Engineering Technology 0.9 Sumitomo Chemical India 1.31 Caplin Point Laboratories 0.88 Aster DM Healthcare 2.81 Aurobindo Pharma 4.55 Apollo Hospitals Enterprise 6.21 Park Medi World 1.31 Glenmark Pharmaceuticals 2.04 Onesource Specialty Pharma 0.93 Glaxosmithkline Pharma 1.05 Piramal Pharma 1.2 Laurus Labs 1.9 Divi's Laboratories 8.96 Max Healthcare Institute 5.49 Sai Life Sciences 1.57 Shilpa Medicare 0.68 Cipla 1.81 Orchid Pharma 1.2 Alkem Laboratories 3.36 Sun Pharmaceutical Industries 10.76 SBI Life Insurance Company 1.41 Fortis Healthcare 3.66 Torrent Pharmaceuticals 4.98 Ipca Laboratories 1.57 Supriya Lifescience 0.81 Poly Medicure 0.87 Mankind Pharma 1.97 Healthcare Global Enterprises 1.33 Rainbow Children's 1.09 Biocon 1.32 Neuland Laboratories 2.65 Dr. Reddy's Laboratories 1.83 FDC 1.37 Wockhardt 2.55 Lupin 3.69 Linde India 1.23 Zydus Lifesciences 0.71 Abbott India 2.48 Cohance Lifesciences 2.65 Syngene International 0.39
Debt & Others (1.76%) Sector Allocation Net Receivables 1.76 Debt Credit Ratings Debt Category Others 1.76
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -0.94% Ret 1Y 5.79% Ret 3Y 22.15% Ret 5Y 13.29%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -0.94% Ret 1Y 5.79% Ret 3Y 22.15% Ret 5Y 13.29%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -0.94% Ret 1Y 5.79% Ret 3Y 22.15% Ret 5Y 13.29%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -1.82% Ret 1Y 3.4% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -1.82% Ret 1Y 3.4% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -1.82% Ret 1Y 3.4% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -1.78% Ret 1Y 3.3% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M -2.11% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M -2.11% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M -2.11% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -1.01% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 2.35%
Exit Load 0.5%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Rajesh Bhatia
Education Mr. Bhatia has done B.Com, ACMA and CFA
Experience Prior to joining ITI Mutual Fund, he was associated with The Investment Trust Of India Ltd, Simto Investment Company Ltd, ProAlpha Systematic Capital, Heritage India Advisors Ltd and Reliance Capital Asset Management Ltd
Dhimant Shah
Education Mr. Shah is a B.Com (H) and Chartered Accountant.
Experience Prior to joining ITI Mutual Fund, he has worked with Principal Mutual Fund, HSBC AMC, Reliance Mutual Fund, ASK Raymond James Securities Pvt. Ltd. and IL&FS AMC. Senior Analyst from April 1997 to August 2003.
Rohan Korde
Education Mr. Korde is a Masters in Management Studies (Finance), Bachelor of Commerce
Experience Prior to joining ITI Mutual Fund, he has worked with BOB Capital Markets as Vice President
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 28
Date of Incorporation 2021-11-08
Total AUM 2026-01-31
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.